Investing.com - Santhera Pharmas Holding reported on Thursday second quarter earnings that matched analysts' forecasts and revenue that was inline with expectations.
Santhera Pharmas Holding announced earnings per share of CHF-0.20 on revenue of CHF1.7M. Analysts polled by Investing.com anticipated EPS of CHF-0.20 on revenue of CHF1.7M.
Santhera Pharmas Holding shares are down 41.35% from the beginning of the year and are trading at CHF1.31 , down-from-52-week-high.
Santhera Pharmas Holding follows other major Healthcare sector earnings this month
Santhera Pharmas Holding's report follows an earnings matched by Abcam on September 12, who reported EPS of CHF0.14 on revenue of CHF185.2M, compared to forecasts EPS of CHF0.14 on revenue of CHF194.64M.
Oxford Nanopore Tech had beat expectations on September 13 with second quarter EPS of CHF-0.04 on revenue of CHF122.3M (NYSE:MMM), compared to forecast for EPS of CHF-0.08 on revenue of CHF72.50M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar